Save info   Get password
Home Submit your blog Edit Account Rules RSS-Archive Contact


Smart tools to track, analyze and visualize research II
2008-07-22 08:17:00
Previously blogging about Smart tools to track, analyze and visualize research discussed about the latest trends in literature abstraction, alert services and analysis tools. This time as a sequel check out one of the finest alert service using the web 2.0 technology. It is absolutely FREE! It is very simple, just visit the site www.xtractor.in and register. Almost immediately you are provided wit


18 Ways to Improve your PubMed searches
2008-07-22 06:56:00
18 Ways to Improve your PubMed searchesBe a part of the XTractor community. XTractor is the first of its kind - Literature alert service, that provides manually curated and annotated sentences for the Keywords of user preference. XTractor maps the extracted entities (genes, processes, drugs, diseases etc) to multiple ontologies and enables customized report generation. With XTractor the sentence


IBM to provide a server platform for analyzing protein structure and function.
2008-07-22 00:19:00
Bioinformatics firm Biosof said today that it is working with IBM to provide a server platform for its PredictProtein product for analyzing protein structure and function . The collaboration will enable Biosof’s customers to use ProteinPredict through a virtual private network or on-site installation while running IBM’s high-performance computing hardware, New York-based Biosof said in a stat


Launch of XTractor™ -a powerful scientific literature alert & abstraction system, now with unlimited free access.
2008-07-18 05:53:00
Bangalore, India — Indian Life Sciences Informatics Company, Molecular Connections announced today, the release of XTractor™, a first of its kind manually curated literature alert service. XTractor™ can be accessed free of charge by the scientific community world wide. XTractor™ acts as a literature alert service, which provides scientists with manually annotated scientific facts fr
Read more: Launch

Sigma-Aldrich continues to make the Acta more useful and accessible to scientists around the world
2008-07-16 05:19:00
Sigma-Aldrich announced that its highly acclaimed chemistry review journal, Aldrichimica Acta, has again been ranked #1 by Impact Factor, out of 56 similar journals in the field of Organic Chemistry. In 2007, the latest year for which such rankings are available, the Acta achieved an Impact Factor of 11.929. The Acta was also ranked #1 in 2006 and 2005. These rankings appear annually in the Scienc
Read more: Sigma , scientists

Molecular Connections bags the most coveted ‘The Small Enterprise of the Year’ award at the “Emerging India” Awards organized by ICICI-CNBC.
2008-07-15 07:06:00
14 July 2008Molecular Connections bags the most coveted ‘The Small Enterprise of the Year’ award at the “Emerging IndiaAwards organized by ICICI -CNBC. Molecular Connections Private Ltd. (MC) – a pioneering life-sciences informatics company from India was adjudged the most promising company of the year by CNBC-ICICI for the Emerging India Awards out of more than 3,00,000 entries.The awa


Merck & Co., Pfizer, and Eli Lilly partnered with PureTech Ventures & form new firm called Enlight Biosciences
2008-07-14 06:48:00
Now this looks very interesting, three pharma big wigs getting together for something they have in common. The firm would cater to the niche requirement these pharmas have in the area of drug discovery. Enlight Biosciences will them the power to speed development of drug-discovery tools. The three pharmas and PureTech have ponied up a total of $39 million that Enlight will direct toward “brea
Read more: Merck , Pfizer , Lilly , Ventures

CNBC-TV18's Emerging India Award salutes best SME players
2008-07-09 05:04:00
Molecular Connections bagged the ‘Small Enterprise of the Year’ title. It was also the winner of the non-retail trade category.CNBC-TV18's Emerging India Award recognised the achievements of those SMEs (Small and Medium Enterprises), which dared to think global in a glittering function in London, on Tuesday.Microqual Techno - a company that provides microwave components to telecom operators wa
Read more: salutes

Top 25 Indian Bioinformatics Companies
2008-07-08 01:36:00
Here is another, quite interesting blog page with a list of Top 25 Indian Bioinformatics Companies by a fellow blogger Nabeel Basheer, while there is no actual criteria behind listing these 25 companies. It is a good handy list just in alphabetic order for all those job seekers. More so a good chronicle of the local informatics industry as well. 1. Accelrys Software Solution Pvt Ltd.12th Floor, Di


THE ROLE OF PHYTOHORMONES TO ENHANCE THE EXPRESSION OF LIPID TRANSFER PROTEIN3 (LTP3) IN IMPROVING STAPLE LENGTH OF Gossypium hirsutum L.
2008-07-08 00:36:00
Here is a abstract that i had submitted at the Plant & Animal Genomes XI Conference January 11-15, 2003 Town & Country Convention Center San Diego, CA. I do not know how relevant is the issue to this day. If any one is interested or if any one is working in these lines, do let me know also pour in your suggestions and comments if any.Fiber quality in cotton is one very vital trait demandin


New antibiotic beats superbugs...
2008-07-07 02:31:00
The problem with antibiotics is that, eventually, bacteria outsmart them and become resistant. But by targeting the gene that confers such resistance, a new drug may be able to finally outwit them. Rockefeller University scientists tested the new drug, called Ceftobiprole, against some of the deadliest strains of multidrug-resistant Staphylococcus aureus (MRSA) bacteria, which are responsible for


Researchers Develop Tool To Study Genes
2008-07-07 02:09:00
Two Texas A&M University researchers have developed a computational tool that will help scientists more accurately study complex units of clustered genes, called operons, in bacteria. The tool, which allows scientists to analyze many bacterial genomes at once, is more accurate than previous methods because it starts from experimentally validated data instead of from statistical predictions, th
Read more: Study , Genes

Ranbaxy, others to scrap 60 drug combinations
2008-07-07 02:05:00
The country's leading drug makers, including Ranbaxy Laboratories, Cipla, Cadila Pharmaceuticals, Nicholas Piramal and Wockhardt, will soon withdraw about 60 drug combinations from the market.The voluntary move comes a little more than a year after the Central Drugs Standard Control Organisation (CDSCO), the central authority that approves new drugs for marketing, had asked the drug makers to with


Molecular Connections to acquire firm in Europe
2008-07-03 23:35:00
The company provides database products to pharmaceutical companies for drug discovery and development. Betting big on the transition taking place in the global pharmaceutical industry, the company is now looking to grow through both inorganic and organic routes. Molecular Connections is a joint venture between Idea2solutions, a venture capital arm promoted by the founders of Dr Reddy's group and a
Read more: Europe

Singapore Attracts Life Science Companies
2008-06-30 07:38:00
Today, Singapore continues to capitalize on its geographic location as one of the crossroads of the world to grow life science companies. About 70 airlines serve Singapore, making it a gateway to Southeast Asia.As a testament to their commitment to the life science industry in the 21st century, Singapore built two state-of-the-art biomedical research parks. The Biopolis, a biomedical research comp
Read more: Companies , Science

Novel therapies for age-related diseases such as Alzheimer's and Parkinson's
2008-06-30 01:45:00
In their current study, published in the online edition of the journal Nature, Conboy and her team found that old muscle produces elevated levels of a molecule called TGF-beta, which is known to inhibit muscle growth. The researchers then showed that the muscle-deteriorating effects of TGF-beta can be reversed by blocking its pathway in old mice. In the experiments, the researchers used RNA inter
Read more: related , Alzheimer , Parkinson

Reading Between Lines
2008-06-27 06:33:00
In the series of blogs on the aftermath of GINA, first it was the consumers GINA Aftermath - Consumers Still Wary of Genetic Tests and now its the turn of the firms Gene Testing Questioned by Regulators , Consumer Genomics Firms Confused by California's Actions; State Seeks Federal Solution be is consumer or the firm no body is spared, as President Bush often quips "justice is served" and all are
Read more: Reading , Lines

CRANKITE: A fast polypeptide backbone conformation sampler
2008-06-26 06:53:00
Background: CRANKITE is a suite of programs for simulating backbone conformations of polypeptides and proteins. The core of the suite is an efficient Metropolis Monte Carlo sampler of backbone conformations in continuous three-dimensional space in atomic details. Methods: In contrast to other programs relying on local Metropolis moves in the space of dihedral angles, our sampler utilizes local cra


The new beta version of UniProt
2008-06-26 04:49:00
Recently took a peek at the new version of UniProt. It has some exciting features on customized searches, filtering results using key words, customize the results view and cross references to Public databases including the 3D- viewers. Try taking the SITE tour on the right hand side panel. This is a beta version of the their new web site, most welcome to give your feedback. Please take i


Roche Acquires Early-Stage Cancer Drug In US$778mn Deal
2008-06-26 01:38:00
In keeping with Roche's commitment to developing cancer therapies, the company has acquired worldwide exclusive rights to an early stage cancer therapy that is being co-developed by Belgian biopharmaceutical firm Thrombogenics and Swedish antibody developer BioInvent. Under the agreement the two companies will share an upfront payment of EUR50mn (US$78mn) plus up to EUR450mn (US$700mn) based on re
Read more: Early , Stage , Cancer

Controlling HIV Evolution
2008-06-25 07:57:00
Dr. Ronald Collman talks about exciting new discoveries on HIV, the virus that has taken 25 million lives. Dr. Ronald Collman, professor of medicine in microbiology, virus/cell/molecular core director, Penn Center for AIDS Research, University of Pennsylvania.He describes the molecular structure, pathology, and with great insight, the incredible discoveries that might just help us conquer HIV.List
Read more: Controlling , Evolution

In Silico Transfer of Neurotransmitter Transporter Motif Between Structurally Analogous Protein (Catechol-O-methyltransferase)
2008-06-20 02:27:00
Here is a abstract that i had submitted at the 3D sig:Structral Bioinformatics at the 1st Structural Bioinformatics Meeting at ISMB 29-30 July 2004, Glasgow, Scotland, UK. I do not know how relevant is the issue to this day. I am interested in working further in this area and i am interested in collaborating. Do let me know your comments also pour your suggestions on how to further this study.In s
Read more: Transporter

XTRACTOR™ Data Mining Simplified
2008-06-18 07:32:00
The first of its kind - SCIENTIFIC LITERATURE alert service which also provides manually annotated sentences for the keywords of YOUR preference Highly accurate, manually annotated sentences for given keywords.Daily scientific literature updates at your desktop along with extracted facts - manually curated.Provision to change keywords with your changing research preferences.Annotated sentences an
Read more: Mining , Data Mining

GINA Aftermath - Consumers Still Wary of Genetic Tests
2008-06-18 06:46:00
Previously blogging on GINA Dawn of the GATTACA era! now Industry Survey Shows: The surveyors found that only five percent of consumers said that they were “very likely” to take a disease-specific genetic test in the next few years, and 15 percent said they would be “likely” to take one. A total of 35 percent said that they would not submit to genetic tests, with 14 percent citing concer
Read more: Aftermath

Boehringer Ingelheim to Acquire Actimis Pharmaceuticals for $515M
2008-06-18 06:42:00
Boehringer Ingelheim will acquire Actimis Pharmaceuticals through a structured buyout in which Boehringer Ingelheim will acquire shares of Actimis depending on the achievement of several successive milestones with Actimis’ leading asthma compound AP768.If AP768, currently in Phase I development, is successfully advanced into a Phase III, Boehringer Ingelheim will own 100% of Actimis’ shares. U
Read more: Acquire

Research Exposes New Target For Malaria Drugs
2008-08-07 06:32:00
The malaria parasite has waged a successful guerrilla war against the human immune system for eons, but a study in this week's Journal of Biological Chemistry has exposed one of the tricks malaria uses to hide from the immune proteins, which may aid in future drug development. Malaria parasites (plasmodia) are transmitted to people via infected mosquitoes. Once inside their human hosts the parasit
Read more: Research , Target , Drugs

180 jobs to go at Pfizer in Cork
2008-08-07 06:24:00
180 jobs are to go in Cork after pharmaceutical giant Pfizer announced it had failed to find a buyer for one of its five manufacturing facilities in Ireland. For the past 18 months, the company had been actively trying to sell the facility at Little Island as a going concern and retain employment there. However the sale fell through last month and the company says the facility will now closed by t


Market study reveals 20 per cent growth for ELNs
2008-08-07 02:03:00
Atrium Research has published the 2008 Electronic Laboratory Notebook Survey. This study contains the results and analysis of a survey of information technology, management, and scientific personnel in the life sciences, chemical, academic, government and food markets. Comprehensive data and analysis are reported on dozens of questions answered by 527 professionals from more than 20 countries. The
Read more: Market , per cent

Roche tipped to be world's top drugmaker by 2014
2008-08-07 01:39:00
Switzerland's Roche Holding AG is set to become the world's biggest drugmaker by sales in 2014, as current market leader Pfizer Inc skids down the rankings to sixth place, according to a study on Monday. The realignment of the global drugs industry reflects the looming "cliff" of patent expiries, which will see many of the world's top-selling medicines cannibalized by cheap generics over the next


The goal should be to teach students how to think and not how to work at a bench.
2008-08-05 05:02:00
Here a very noble thought "Science programs often pretend to be career oriented but they should be knowledge oriented. The main goal should be to teach students how to think and not how to work at a bench. Thus, students who graduate from an undergraduate—or graduate—program will have valuable skills that they can use in any career they choose." Brought out really well in this blog article ch


Page 1 of 3 « < 1 2 3 > »
eXTReMe Tracker